Gary Zenitsky

Gary Zenitsky is a Researcher in the Department of Physiology and Pharmacology at the University of Georgia’s College of Veterinary Medicine. His research focuses on neurodegenerative mechanisms, environmental toxin impacts, and mitochondrial dysfunction in diseases like Parkinson’s. Key areas of investigation include neuroinflammation, protein misfolding, and the gut-brain axis. His work bridges molecular biology, toxicology, and translational medicine.

Recent studies emphasize the roles of α-synuclein, mitochondrial stress, and environmental exposures in neurodegenerative processes. He explores innovative approaches like microbiome engineering for therapeutic delivery. His research often involves collaborative interdisciplinary methods, including CRISPR-Cas9 systems and advanced cell culture models.

Notable contributions include identifying KCa3.1 channels as targets in neuroinflammatory pathways and elucidating manganese’s role in promoting α-synuclein aggregation. He has pioneered methods for isolating primary microglia with enhanced purity, advancing in vitro studies of neuroinflammation.

Zenitsky’s work addresses translational challenges in neurotoxicology and neurodegenerative disease treatment. Current projects investigate biomarkers for early Parkinson’s detection and environmental risk factor mitigation strategies.